HOXB13 and ependymal tumor: In contrast, gains of whole chromosome 16 were observed in 5/12 of the strongly HOXB13-positive ependymal tumors corresponding to the MPE methylation class subsets, while none of the 10 molecularly confirmed SP-EP had gains on chromosome 16 (p < 0.05, Fisher’s exact test) (Suppl.